Radiology Business January 23, 2025
Marty Stempniak

The use of a key interventional radiology procedure for kidney cancer has declined in recent years, with reimbursement a likely factor, according to new research published Tuesday.

Renal cell carcinoma is the ninth most common cancer in the U.S., and its incidence has doubled over the past 50 years. Total removal of the kidney is the most common approach, though emerging IR alternatives can help preserve the organs’ function while curbing high surgical costs, experts detailed in Clinical Imaging.

Such image-guided ablation, however, remains woefully underutilized among hospital inpatients. Across nearly 184,000 hospitalized individuals, fewer than 2% underwent the minimally invasive procedure, which uses a small incision and heat or cold to destroy the tumor. That’s compared to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider, Radiology
Rayus Radiology names new CEO, plus more leadership moves at Envision, Penn Medicine and St. Jude
Aidoc scores ‘significant’ investment from Amazon, seeks to flesh out radiology foundation model
AI models show numerous applications and benefits for radiology
AI Outperforms Human Readers at Coronary CTA Analysis
ONRAD Inc. Acquires Direct Radiology in a Move That Expands Capabilities, Enhances Quality and Outcomes

Share This Article